323 results on '"Deighton C"'
Search Results
2. Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long-Term Treatment Response in Rheumatoid Arthritis
3. Testing the role of vitamin D in response to antitumour necrosis factor α therapy in a UK cohort: a Mendelian randomisation approach
4. Anti-TNF-α Agents Are Less Effective for the Treatment of Rheumatoid Arthritis in Current Smokers
5. Why do the French get much greater access to anti-TNF than the British? Vive la différence? Pas nécessairement
6. The importance of the baseline Disease Activity Score 28 in determining responders and non-responders to anti-TNF in UK clinical practice
7. Rheumatoid cachexia: a clinical perspective
8. An update on UK rheumatology consultant workforce provision: the BSR/ARC Workforce Register 2005–07: assessing the impact of recent changes in NHS provision
9. Three significant cases of neutropenia with etanercept
10. Discrepancies between the EULAR response criteria and the NICE guidelines for continuation of anti-TNF therapy in RA: a cause for concern?
11. Is it ever appropriate to discharge patients with rheumatoid arthritis?
12. Is pre-assessment for anti-TNF therapy in RA necessary in the UK? Analysis of DAS28 in six centres
13. The impact of the NICE appraisal consultation document on anti-TNF therapy for ankylosing spondylitis
14. An unusual association with Raynaudʼs phenomenon
15. Psoriatic arthritis patients doing better on infliximab than etanercept
16. Characteristics and treatment responses of patients satisfying the BSR guidelines for anti-TNF in ankylosing spondylitis
17. Ages of onset suggestive of genetic anticipation in rheumatoid arthritis multicase sibships can be explained by observational bias
18. The impact of anti-tumour necrosis factor therapy for rheumatoid arthritis on the use of other drugs and hospital resources in a pragmatic setting
19. Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis
20. Undergraduate musculoskeletal examination teaching by trained patient educators—a comparison with doctor-led teaching
21. An error in the revised anti-TNF therapy guidelines for adult RA
22. Meeting the needs of increasing numbers of medical students—a best practise approach
23. Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again)
24. Life threatening intra-abdominal sepsis in patients on anti-TNF-α therapy
25. Re: Aouba et al. Crowned dens syndrome misdiagnosed as polymyalgia rheumatica, giant cell arteritis, meningitis or spondylitis
26. British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-α treatments
27. The updated BSR Guidelines for anti-TNF in adult RA: advice on septic arthroplasties
28. The perceptions of final year medical students in rheumatology workshops when delivered by a consultant and a nurse clinical educator
29. Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)
30. Delayed multiple injection site reaction in a rheumatoid arthritis patient treated with etanercept
31. Do guidelines for the prescribing and monitoring of leflunomide need to be modified?
32. Rheumatologists and breasts: immunosuppressive therapy for granulomatous mastitis
33. The Efficacy and Safety of Leflunomide in Patients With Active Rheumatoid Arthritis: A Five-Year Followup Study
34. The joys of online submission
35. Treatment of SAPHO with pamidronate
36. The impact of psoriatic arthritis in primary and secondary care
37. Bacteria And Arthritis
38. Eosinophilia Myalgia Syndrome
39. BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy (vol 49, pg 1197, 2010)
40. Life threatening intra-abdominal sepsis in patients on anti-TNF-[alpha] therapy
41. SAT0113 Common trajectories of HAQ disability progression over 15-years in the early rheumatoid arthritis study and the norfolk arthritis register
42. Essentials in Rheumatology: Disease Management * I29. Recognition and Management of the Auto-Inflammatory Diseases
43. Musculoskeletal research--opportunities for all?
44. What is meant by active disease in the NICE recommendation on use of combination therapy in early RA?
45. Treatment of rheumatoid arthritis is good medicine
46. Rheumatologists at training: IP21. Understanding Health Policies, Nice and Guidelines: What every Trainee Needs to Know. A View of Musculoskeletal Health Policy
47. Treating inflammatory arthritis early
48. If it works why can't we have it? Sequential anti-TNF therapy in the UK
49. Concurrent Oral 5 - BHPR Audit/Service Delivery and Research [OP32-OP39]: OP32. Is Nurse-Led Care Effective in Rheumatology? a Systematic Review
50. BHPR: Audit/Service Delivery [239-277]: 239. Arma-Based Audit of Rheumatology Service Delivered Predominantly Outside the Traditional Hospital Setting
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.